NCT06645808 - PET-imaging of Two Vartumabs in Patients With Solid Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 10, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions

Solid TumorColon CarcinomaRectal CarcinomaOsteosarcomaChondrosarcomaLung CarcinomaHead and Neck Squamous Cell CarcinomaEsophageal CarcinomaGastric CarcinomaPancreas CarcinomaBladder CarcinomaGlioblastoma

Interventions

BIOLOGICAL

89Zr-DFO-N-Suc-F8scFv

89-Zirconium labeled short-chain variable fragment F8 targeting oncofetal CS.

BIOLOGICAL

89Zr-DFO-N-Suc-C9scFv

89-Zirconium labeled short-chain variable fragment C9 targeting oncofetal CS.

RADIATION

PET/CT scan

IMP administration will be followed by PET/CT scans on day 1, 2 and 4.

Trial Locations (1)

9713GZ

RECRUITING

University Medical Center Groningen (UMCG), Groningen